A company focused on developing novel treatments for mental health this week announced that it has submitted an application to the U.S. Food and Drug Administration seeking the approval of ...

Training supports multi-site clinical trial of MDMA-assisted Massed Prolonged Exposure Therapy for PTSD in active-duty service members. First-of-its-kind therapist preparation supports the Department ...

In an effort to illustrate that genomic surveillance can build the foundation for scaleable precision phage therapy, an international collaboration analyzed the genomes of over 15,000 cases of ...

Do you feel haunted by past experiences? Are anxiety, depression, or intrusive thoughts constantly disrupting your peace? Do you struggle with strained relationships, feeling disconnected and ...

Last summer, thousands of tie-dyed Burners and Patagonia-clad tech founders converged on the MAPS Psychedelic Science conference in Denver. Vendors offered complementary sound baths, Harvard-educated ...

In a prelude to what is hoped will be regulatory approval of MDMA-assisted therapy in the U.S. and Canada, Numinus Wellness Inc. (OTC:NUMIF) has taken steps to get out in front of the curve. Today, ...

Numinus is a leading player in the emerging field of psychedelic therapy. This article delves into their groundbreaking work and collaboration with MAPS (Multidisciplinary Association for Psychedelic ...

Cory Jones of Healing Maps told Benzinga’s Javier Hasse at the inaugural Benzinga Psychedelics Capital Conference on Tuesday that research underway at such institutions as Johns Hopkins University and ...

If approved for medical use, the Drug Enforcement Administration would be required to reschedule the drug. MAPS Public Benefit Corporation is seeking approval of its MDMA (midomafetamine ...